
NRX Pharmaceuticals, Inc.
NRX Pharmaceuticals, Inc. (NRXP)
WebsitePrice
Market cap
Next catalystFirst-in-human ALS trial targeted to commence in July 2027GNK-301 — planned first-in-human ALS trial · Trial initiationSEC filing ↗
Cash

NRX Pharmaceuticals, Inc.